← Back to Patent Explorer
EP0065347A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Process and apparatus for purifying compositions labeled with technetium-99m

Assignee: University Patents Inc
•
Filing: 1982-03-23
•
Granted: —
•
Expires: 2002-03-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions labeled with technetium-99m and suitable for administration to patients are purified by means of a filtration column conveniently in the form of a syringe body (10) purged of oxygen and sealed at its opposite ends. Retained by fluid-passing plugs (14, 16) in the syringe body is a particulate substrate (12) such as cross-linked dextran which is capable of binding reduced technetium (lV oxidation state) and of retaining insoluble technetium moieties such as reduced hydrolysed technetium. The substrate (12) contains a reducing agent prepared in the absence of oxygen and comprising a mixture of colloidal stannous phthalate and an antioxidant such as gentistic acid. In use, a needle is attached to one end of the syringe body in place of one seal and the composition to be purified is drawn therethrough into and through the substrate by means of a second syringe, the needle of which is inserted through a closure seal (20) at the second end of the substrate-containing syringe body.

Inventors

  • 👤 Buck A. Rhodes
  • 👤 David Torvestad

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-23 13:41
CPC Classifications
B; B01; B01D; B01D15/00; A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0474; A61K51/0478; A61K51/048; A61K2123/00; Y; Y10; Y10S; Y10S422/00; Y10S422/903

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 74 words
A process of purifying a composition labeled with technetium-99m and containing unbound reduced technetium and/or pertechnetate impurities, which process is characterised by contacting the labeled composition with a solid particulate substrate capable of binding a technetate ion and also capable of retaining unbound reduced technetium impurity, the substrate being furnished with stannous phthalate precipitated from a saturated solution and a secondary antioxidant, and following contact with the substrate the purified labeled composition is recovered.
Claim 2
Dependent Claim 74 words
A process of purifying a composition labeled with technetium-99m and containing unbound reduced technetium and/or pertechnetate impurities, which process is characterised by contacting the labeled composition with a solid particulate substrate capable of binding a technetate ion and also capable of retaining unbound reduced technetium impurity, the substrate being furnished with stannous phthalate precipitated from a saturated solution and a secondary antioxidant, and following contact with the substrate the purified labeled composition is recovered.
Claim 3
Dependent Claim 16 words
The process according to claim 1, characterised in that the secondary antioxidant present is gentisic acid.
Claim 4
Dependent Claim 16 words
The process according to claim 1, characterised in that the secondary antioxidant present is ascorbic acid.
Claim 5
Dependent Claim 16 words
The process according to claim 1, characterised in that the particulate substrate used is cross-linked dextran.
Claim 6
Dependent Claim 20 words
The process according to any of claims 1 to 4, used to purify a composition comprising 99m TC-labeled methylene diphosphonate.
Claim 7
Dependent Claim 20 words
The process according to any of claims 1 to 4, used to purify a composition comprising 99m Tc-labeled diethylenediaminepentaacetic acid.
Claim 8
Dependent Claim 25 words
The process according to any of claims 1 to 4, used to purify a composition comprising a 99m Tc - lab e l ed protein.
Claim 9
Dependent Claim 51 words
Apparatus for purifying a composition labeled with technetium-99m, which comprises a closed container having an inert non-oxidizing atmosphere and containing a solid particulate substrate capable of binding technetate ion and capable of retaining unbound reduced technetium impurity, the substrate containing stannous phthalate precipitated from a saturated solution and a secondary antioxidant.
Claim 10
Dependent Claim 51 words
Apparatus for purifying a composition labeled with technetium-99m, which comprises a closed container having an inert non-oxidizing atmosphere and containing a solid particulate substrate capable of binding technetate ion and capable of retaining unbound reduced technetium impurity, the substrate containing stannous phthalate precipitated from a saturated solution and a secondary antioxidant.
Claim 11
Dependent Claim 15 words
The apparatus according to claim 8, characterised in that the secondary antioxidant is gentistic acid.
Claim 12
Dependent Claim 15 words
The apparatus according to claim 8, characterised in that the secondary antioxidant is ascorbic acid.
Claim 13
Independent Claim 19 words
The apparatus according to any one of claims 8, 9 and 10, wherein the particulate substrate is cross-linked dextran.
Claim 14
Dependent Claim 46 words
The process according to any of claims 1 to 7, or the apparatus according to any of claims 8 to 11, characterised in that the stannous ion concentration in the substrate is from 2 x 10 -3 to 0.1 x 10 -3 milli- equivalents per millilitre.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag